Literature DB >> 1908818

Association between Rh and plasma iron binding (transferrin).

C Y Valenzuela1, A Avendaño, Z Harb.   

Abstract

In order to establish the mechanism involved in the maintenance of the Rh polymorphism and fetomaternal compatibility relationships, we examined a sample of children from the North Area of Santiago (Chile), with respect to their growth and development patterns since 1973. This sample had shown large sib-sib segregation distortions for the Rh system. Metric variables, such as plasma protein fractions and iron, academic performance at the end of the last secondary grade and adult stature, were studied in relation to genetic markers, viz., sex, ABO, Xg, MN, Rh, haptoglobins, phosphoglucomutase, and esterase D, by means of unbalanced one way analyses of variance. Highly significant results were found for Rh phenotypes and total iron binding capacity (TIBC, transferrin). However, plasma iron did not differ significantly among Ph phenotypes. Children with the C (Rh) specificity had higher values of TIBC than non-C or c individuals (P less than 0.00001). Evolutionary considerations regarding iron transport and erythroblastosis, relationships between Rh and the transferrin receptor at the plasma membrane, and the location of the Blym-I oncogene (that shares common sequences with transferrins) close to Rh in chromosome 1 are discussed. Less significant results were found between phosphoglucomutase and stature, gamma globulin level and sex, and academic performance (history) and sex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908818     DOI: 10.1007/bf00197164

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

Review 1.  An overview of iron metabolism at a molecular level.

Authors:  M Worwood
Journal:  J Intern Med       Date:  1989-11       Impact factor: 8.989

2.  Genetic transferrin types and iron-binding: a comparative study of a European and an African population sample.

Authors:  H Cleve; E Schwendner; A Rodewald; F Bidlingmaier
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

3.  [Patterns and values of plasma and erythrocyte proteins in schoolchildren from 9 to 12].

Authors:  C Valenzuela; O Puratic; M Acuña; Z Harb; A Avendaño; M Bravo
Journal:  Rev Chil Pediatr       Date:  1983 Jul-Aug

4.  [Analysis of Rh blood group in sibships. A new histocompatibility system in man?].

Authors:  C Y Valenzuela; A Avendaño; Z Harb; M Acuña
Journal:  Rev Chil Pediatr       Date:  1981 Mar-Apr

5.  A large phenotypic sib-sib discordance for the Rh blood system. A possible new feto-maternal compatibility system.

Authors:  C Y Valenzuela; Z Harb; A Avendaño; M P Acuña
Journal:  Am J Hum Genet       Date:  1982-07       Impact factor: 11.025

6.  [Hematologic variables in a sample of school children of northern area of Santiago].

Authors:  C Valenzuela; M Bravo; O Puratic; A Avendaño; P Farías; Z Harb; I Morales
Journal:  Rev Chil Pediatr       Date:  1982 Jan-Feb

7.  Acuity of selective mechanisms operating on ABO, Rh, and MN blood groups.

Authors:  C R Srikumari; J Rajanikumari; T V Rao
Journal:  Am J Phys Anthropol       Date:  1987-01       Impact factor: 2.868

8.  A mother-child segregation distortion for the Rh system. New evidence for another compatibility system associated with Rh.

Authors:  C Y Valenzuela; Z Harb
Journal:  Am J Hum Genet       Date:  1982-11       Impact factor: 11.025

9.  Clinical, immunologic, and genetic definitions of primary and secondary recurrent spontaneous abortions.

Authors:  J A McIntyre; P R McConnachie; C G Taylor; W P Faulk
Journal:  Fertil Steril       Date:  1984-12       Impact factor: 7.329

10.  Segregation distortion in Rh polymorphism.

Authors:  J Rajanikumari; C R Srikumari
Journal:  Anthropol Anz       Date:  1987-12
View more
  1 in total

1.  Rh--plasma iron binding capacity association. New evidence.

Authors:  C Y Valenzuela; M L Bravo; J C Alarcón
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.